| Literature DB >> 28428535 |
Dong-Hwan Jung1, Shin Hwang1, Gi-Won Song1, Chul-Soo Ahn1, Deok-Bog Moon1, Ki-Hun Kim1, Tae-Yong Ha1, Gil-Chun Park1, Wan-Jun Kim1, Woo-Hyoung Kang1, Seok-Hwan Kim1, Sung-Gyu Lee1.
Abstract
Background Material and Methods Results Conclusions.Entities:
Keywords: Allografts; Korea; Liver Cirrhosis
Mesh:
Year: 2017 PMID: 28428535 PMCID: PMC6248301 DOI: 10.12659/AOT.902567
Source DB: PubMed Journal: Ann Transplant ISSN: 1425-9524 Impact factor: 1.530
Donor profiles for two-adult split liver transplantation.
| Donor No. | Sex | Age (yrs) | Height (cm) | Weight (kg) | BMI (kg/m2) | Total bilirubin (mg/dL) | Maximum AST (U/L) | Maximum ALT (U/L) |
|---|---|---|---|---|---|---|---|---|
| 1 | Male | 22 | 175 | 60 | 19.6 | 0.7 | 22 | 17 |
| 2 | Male | 24 | 167 | 66 | 23.7 | 0.6 | 62 | 16 |
| 3 | Male | 27 | 181 | 72 | 22.0 | 0.8 | 119 | 63 |
| 4 | Male | 20 | 180 | 80 | 24.7 | 0.8 | 83 | 53 |
| 5 | Male | 30 | 184 | 75.4 | 22.3 | 0.8 | 159 | 76 |
| 6 | Male | 14 | 176 | 64 | 20.7 | 0.9 | 68 | 61 |
| 7 | Male | 21 | 178 | 120 | 37.9 | 1.1 | 25 | 63 |
| 8 | Male | 48 | 173 | 75 | 25.1 | 0.9 | 33 | 12 |
ALT – alanine transaminase; AST – aspartate transaminase; BMI – body mass index.
Recipient profiles of two-adult split liver transplantation.
| Recipient No. | Sex | Age (yrs) | Height (cm) | Weight (kg) | BMI (kg/m2) | GRWR | MELD score | UNOS status | CIT (min) | Primary diagnosis |
|---|---|---|---|---|---|---|---|---|---|---|
| 1-RL | Male | 57 | 165.0 | 55.2 | 20.3 | 2.24 | 18 | 2B | 144 | HBV-LC |
| 2-RL | Male | 42 | 170.9 | 70.0 | 24.0 | 1.36 | 12 | 2B | 307 | HBV-LC |
| 3-RL | Male | 53 | 174.0 | 57.0 | 18.8 | 1.47 | 40 | 2A | 302 | HBV-LC |
| 4-RL | Male | 46 | 176.0 | 67.8 | 21.9 | 1.77 | 30 | 2A | 172 | HBV-LC |
| 5-RL | Female | 52 | 162.0 | 56.9 | 21.7 | 2.11 | 31 | 2A | 101 | ALD |
| 6-RL | Female | 51 | 155.3 | 51.5 | 21.4 | 1.94 | 21 | 2A | 55 | HBV-LC |
| 7-RL | Male | 64 | 165.5 | 71.6 | 26.1 | 1.68 | 19 | 2A | 334 | HBV-LC |
| 8-RL | Female | 63 | 152.0 | 56.8 | 24.6 | 1.58 | 8 | 3 | 386 | HBV-LC |
| 1-LL | Male | 37 | 167.7 | 56.4 | 20.0 | 1.24 | 23 | 2A | 265 | HBV-ALF |
| 2-LL | Female | 32 | 164.3 | 58.3 | 21.6 | 0.99 | 16 | 2B | 544 | Re-LT |
| 3-LL | Male | 55 | 149.0 | 48.0 | 21.6 | 1.15 | 33 | 2A | 217 | HBV-LC |
| 4-LL | Male | 51 | 167.0 | 59.0 | 21.2 | 1.19 | 19 | 2B | 123 | HBV-LC |
| 5-LL | Female | 25 | 157.5 | 50.1 | 20.2 | 1.44 | 19 | 2B | 120 | PSC |
| 6-LL | Male | 40 | 173.8 | 97.1 | 32.2 | 1.04 | 10 | 3 | 275 | HBV-LC |
| 7-LL | Male | 61 | 160.9 | 51.4 | 19.8 | 1.67 | 23 | 2B | 354 | HBV-LC |
| 8-LL | Female | 61 | 140.5 | 37.8 | 19.2 | 1.72 | 19 | 2A | 384 | Ischemia |
The primary disease was Caroli disease and the patient underwent whole liver transplantation. However, she developed graft failure at 12 years post-transplantation.
The patient underwent dual-graft liver transplantation with combination of a left liver graft from a living donor and a left liver graft from deceased donor splitting.
The patient experienced ischemic liver disease after cardiac arrest.
ALD – alcoholic liver disease; BMI – body mass index; CIT – cold ischemic time; GRWR – graft-recipient weight ratio; HBV-ALF – hepatitis B virus-associated acute liver failure; HBV-LC – hepatitis B virus-associated liver cirrhosis; LL – left liver graft; MELD – Model for End-Stage Liver Disease; PSC – primary sclerosing cholangitis; re-LT – re-transplantation; RL – right liver graft; UNOS – United Network for Organ Sharing.
Operative techniques for two-adult split liver transplantation.
| Graft type | Caval drainage | Bile duct | Portal vein | Artery | Graft type | Caval drainage | Bile duct | Portal vein | Artery |
|---|---|---|---|---|---|---|---|---|---|
| 1-RL | Piggyback | RHD, DD | Right PV | Right HA | 1-LL | Bicaval | CBD, DD | Main PV | Celiac axis |
| 2-RL | Piggyback | RHD, HJ | Right PV | Right HA | 2-LL | Bicaval | CBD, HJ | Main PV | Celiac axis |
| 3-RL | Piggyback | RHD, DD | Right PV | Right HA | 3-LL | Bicaval | CBD, DD | Main PV | Celiac axis |
| 4-RL | Piggyback | RHD, DD | Right PV | Right HA | 4-LL | Bicaval | CBD, DD | Main PV | Celiac axis |
| 5-RL | Piggyback | RHD, DD | Right PV | Right HA | 5-LL | Bicaval | CBD, DD | Main PV | Celiac axis |
| 6-RL | Bicaval | CBD, DD | Main PV | Celiac axis | 6-LL | Piggyback | LHD, HJ | Left PV | Left HA |
| 7-RL | Piggyback | RHD, DD | Right PV | Right HA | 7-LL | Bicaval | CBD, DD | Main PV | Celiac axis |
| 8-RL | Piggyback | RHD, DD | Right PV | Right HA | 8-LL | Bicaval | CBD, DD | Main PV | Celiac axis |
CBD – common bile duct; DD – duct to duct anastomosis; HA – hepatic artery; HJ – hepaticojejunostomy; LHD – left hepatic duct; LL – left liver graft; PV – portal vein; RHD – right hepatic duct; RL – right liver graft.
Figure 1Patient survival (A) and graft survival (B) curves of split liver transplantation for 2 adult recipients.
Figure 2Comparison of patient survival (A) and graft survival (B) curves of split liver transplantation for 2 adult recipients according to split hemi-liver graft types.
Major complications after two-adult split liver transplantation according to the Clavien-Dindo classification.
| Grade | Right liver graft | Left liver graft |
|---|---|---|
| II | Liver abscess (n=1) | |
| IIIa | Biliary stricture (n=1) | Biliary stricture (n=1) |
| IIIb | Portal vein stenosis (n=1) | |
| IVa | Primary non-function (n=1) | |
| IVb | ||
| V | Pneumonia (n=1) | Sepsis (n=1) |
One right liver graft recipient experienced early right hepatic vein stenosis and late biliary stricture.
One left liver graft recipient showed early portal vein stenosis requiring portal vein stenting and primary non-function requiring re-transplantation.
Comparison of clinical profiles of recipients who underwent split liver transplantation and whole liver transplantation.
| Split liver transplantation (n=16) | Whole liver transplantation (n=393) | p-value | |
|---|---|---|---|
| Sex (Male/Female) | 16/0 | 267/126 | 0.002 |
| Age (yrs) | 24±11.7 | 42.5±13.9 | 0.000 |
| BMI (kg/m2) | 25.2±5.6 | 23.2±3.3 | 0.36 |
| Sex (Male/Female) | 11/5 | 266/127 | 0.58 |
| Age (yrs) | 49.6±11.7 | 49.3±10.8 | 0.84 |
| BMI (kg/m2) | 22.2±3.3 | 24.0±4.4 | 0.02 |
| Diagnosis (n) | 0.17 | ||
| HBV-LC | 11 | 222 | |
| Alcoholic liver disease | 1 | 60 | |
| HCV-LC | 0 | 14 | |
| Cryptogenic LC | 0 | 11 | |
| Wilson disease | 0 | 6 | |
| Primary biliary cirrhosis | 0 | 6 | |
| Primary sclerosing cholangitis | 1 | 2 | |
| Autoimmune hepatitis | 0 | 4 | |
| Acute liver failure – toxic | 0 | 29 | |
| Acute liver failure – HBV | 1 | 13 | |
| Acute liver failure – HAV | 0 | 9 | |
| Acute liver failure – others | 0 | 6 | |
| Others | 2 | 11 | |
| CTP score | 9.7±2.7 | 11.0±2.1 | 0.03 |
| MELD score | 21.2±8.5 | 28.4±10.7 | 0.01 |
| Pretransplant ventilator | 18.8% | 33.8% | 0.16 |
| Pretransplant dialysis | 31.3% | 31.0% | 0.56 |
| Pretransplant inotropics | 25% | 19.6% | 0.39 |
| Cold ischemic time (min) | 309.6±188.5 | 237.5±128.6 | 0.11 |
| Posttransplant hospital stay (days) | 33.8±18.3 | 46.8±49.9 | 0.75 |
BMI – body mass index; CTP – Child-Turcotte-Pugh; HAV – hepatitis A virus; HBV – hepatitis B virus; HCV – hepatitis C virus; LC – liver cirrhosis; MELD – model for end-stage liver disease.
Figure 3Comparison of patient survival (A) and graft survival (B) curves of recipients who underwent split liver transplantation and whole liver transplantation from deceased donors.
Published outcomes of full right-liver and left-liver split liver transplantation for two adult recipients.
| Authors | Publication year | Nation | Center | Median follow-up (months) | Split Liver Transplantation | Control Group | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | FRLG | FLLG | Splitting | OPS | OGS | FRLG-PS | FRLG-GS | FLLG-PS | FLLG-GS | Graft Type | Patient No. | OPS | OGS | p-Value | |||||
| Humar [ | 2001 | USA | Single | 9.3 | 12 | 6 | 6 | 83.3% | 83.3 | – | – | – | – | – | – | – | – | – | |
| Azoulay [ | 2001 | France | Singe | – | 34 | 17 | 17 | Combined | – | – | 2 yrs, 74% | 2 yrs, 74% | 2 yrs, 64% | 2 yrs, 43% | WLT | 88 | 2 yrs, 85% | 2 yrs, 85% | ND |
| Zamir [ | 2002 | USA | Single | – | 6 | 3 | 3 | 2 deaths | 2 deaths | – | – | – | – | – | – | – | – | – | |
| Broering [ | 2005 | Germany | Single | 27.4 | 35 | 16 | 19 | Mix | – | – | 87.5% | 75% | 89.5% | 84% | – | – | – | – | – |
| Giacomoni [ | 2008 | Italy | Single | 57.37 | 16 | 9 | 7 | 5 yrs, 80% | – | – | – | – | – | – | – | – | – | – | |
| Zambelli [ | 2012 | Italy | Multi | 106.6 | 43 | 21 | 22 | 10 yrs, 62.6% | 10 yrs, 57.9% | 10 yrs, 57.1% | 10 yrs, 57.1% | 10 yrs, 67.9% | 10 yrs, 58.1% | – | – | – | – | – | |
| Lee [ | 2013 | Taiwan | Single | – | 42 | 21 | 21 | 5 yrs, 70.1% | – | – | – | – | – | LDLT | 282 | 5 yrs, 70.4% | – | 0.49 | |
| Aseni [ | 2014 | Italy | Multi | – | 64 | – | – | – | 5 yrs, 63.3% | 5 yrs, 58.7% | 5 yrs, 59.3% | 5 yrs, 56.6% | 5 yrs, 67.2% | 5 yrs, 60.7% | WLT | 1199 | 5 yrs, 83.1% | 5 yrs, 80.4% | 0.0003 |
| Vagefi [ | 2014 | USA | Single | – | 18 | 9 | 9 | – | – | 10 yrs, 74% | 10 yrs, 74% | 10 yrs, 78% | 10 yrs, 66% | – | – | – | – | – | |
| Hashimoto [ | 2014 | USA | Single | 54 | 25 | 15 | 10 | 5 yrs, 88.0% | 5 yrs, 80.0% | 5 yrs, 93.3% | 5 yrs, 86.7% | 5 yrs, 80.0% | 5 yrs, 70.0% | WLT | 121 | 5 yrs, 86.5% | 5 yrs, 81.5% | 0.81-PS | |
| Present study | Korea | Singe | 113.3 | 16 | 8 | 8 | 5 yrs, 81.3% | 5 yrs, 68.8% | 5 yrs, 78.5% | 5 yrs, 87.5% | 5 yrs, 75.0% | 5 yrs, 50.0% | WLT | 393 | 5 yrs, 74.1% | 5 yrs, 72.9% | 0.47-PS | ||
FLLG – full left-liver graft; FRLG – full right-liver graft; GS – graft survival; LDLT – living donor liver transplantation; ND – not different; OGS – overall graft survival; OPS – overall patient survival; PS – patient survival; WLT – whole liver transplantation; ‘−’ – not available.